$WOOF
Petco Health & Wellness Company, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021032462 Filed on June 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $1.415B $1.114B
YoY Change 27.07%
Cost Of Revenue $818.0M $647.2M
YoY Change 26.38%
Gross Profit $597.0M $466.3M
YoY Change 28.03%
Gross Profit Margin 42.19% 41.87%
Selling, General & Admin $549.2M $449.9M
YoY Change 22.07%
% of Gross Profit 92.0% 96.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.61M $43.57M
YoY Change -4.5%
% of Gross Profit 6.97% 9.34%
Operating Expenses $549.2M $449.9M
YoY Change 22.07%
Operating Profit $47.75M $16.37M
YoY Change 191.78%
Interest Expense $20.53M $60.81M
YoY Change -66.24%
% of Operating Profit 42.99% 371.57%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $6.403M -$44.26M
YoY Change -114.47%
Income Tax $2.679M -$10.56M
% Of Pretax Income 41.84%
Net Earnings $7.560M -$31.17M
YoY Change -124.26%
Net Earnings / Revenue 0.53% -2.8%
Basic Earnings Per Share $0.03 -$0.15
Diluted Earnings Per Share $0.03 -$0.15
COMMON SHARES
Basic Shares Outstanding 264.2M 209.0M
Diluted Shares Outstanding 265.0M 209.0M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $174.0M
YoY Change
Cash & Equivalents $174.0M $348.3M
Short-Term Investments
Other Short-Term Assets $42.36M
YoY Change
Inventory $574.7M
Prepaid Expenses $46.72M
Receivables $38.08M
Other Receivables $0.00
Total Short-Term Assets $875.9M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $639.4M
YoY Change
Goodwill $2.179B
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $142.3M
YoY Change
Total Long-Term Assets $5.318B
YoY Change
TOTAL ASSETS
Total Short-Term Assets $875.9M
Total Long-Term Assets $5.318B
Total Assets $6.193B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $352.4M
YoY Change
Accrued Expenses $218.9M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $20.20M
YoY Change
Total Short-Term Liabilities $995.2M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $1.650B
YoY Change
Other Long-Term Liabilities $138.1M
YoY Change
Total Long-Term Liabilities $1.788B
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $995.2M
Total Long-Term Liabilities $1.788B
Total Liabilities $4.121B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$14.69M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.087B
YoY Change
Total Liabilities & Shareholders Equity $6.193B
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $7.560M -$31.17M
YoY Change -124.26%
Depreciation, Depletion And Amortization $41.61M $43.57M
YoY Change -4.5%
Cash From Operating Activities $115.0M -$32.29M
YoY Change -456.16%
INVESTING ACTIVITIES
Capital Expenditures $47.35M $27.90M
YoY Change 69.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$47.35M -$27.90M
YoY Change 69.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.678B $142.3M
YoY Change 1079.17%
Cash From Financing Activities -7.213M 253.8M
YoY Change -102.84%
NET CHANGE
Cash From Operating Activities 115.0M -32.29M
Cash From Investing Activities -47.35M -27.90M
Cash From Financing Activities -7.213M 253.8M
Net Change In Cash 60.44M 193.6M
YoY Change -68.78%
FREE CASH FLOW
Cash From Operating Activities $115.0M -$32.29M
Capital Expenditures $47.35M $27.90M
Free Cash Flow $67.65M -$60.18M
YoY Change -212.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
818009000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherCurrentAssetsMember
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherCurrentAssetsMember
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000.0
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000.0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2103714000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2092110000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14691000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22251000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2061000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1275000
CY2020Q2 us-gaap Gross Profit
GrossProfit
466282000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
47749000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
21000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
184000
CY2021Q2 us-gaap Interest Expense
InterestExpense
20529000
CY2020Q2 us-gaap Interest Expense
InterestExpense
60808000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20838000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6403000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44259000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2217000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3267000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4793000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4793000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4164000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4079000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
629000
CY2020Q2 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7213000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
60438000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
193568000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119540000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154718000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
6958000
CY2020Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
56000
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
218000
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
288000
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
23386000
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
15946000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
142347000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137474000
CY2021Q2 us-gaap Assets
Assets
6193399000
CY2021Q1 us-gaap Assets
Assets
6075702000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
352401000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
339485000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127000000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
129484000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218926000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145846000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
276619000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
258289000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
20234000
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2203000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
995180000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
875307000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1649509000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1646281000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1056059000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1083575000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
282350000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
280920000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
138069000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134354000
CY2021Q2 us-gaap Liabilities
Liabilities
4121167000
CY2021Q1 us-gaap Liabilities
Liabilities
4020437000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2068848000
CY2021Q2 us-gaap Minority Interest
MinorityInterest
-14994000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
-13583000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2072232000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2055265000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6193399000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
714000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6075702000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414994000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2087226000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
647239000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1113521000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2679000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10555000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2425000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
332000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
6149000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-33372000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1411000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2204000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7560000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-31168000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
264215000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
209015000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
265028000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
209015000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
6149000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-33372000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1411000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2204000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7560000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-31168000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-786000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4970000
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-52000
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1728000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-786000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3294000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5363000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-36666000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1411000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2204000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6774000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34462000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2055265000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11604000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-786000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2072232000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
561061000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2305000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-33372000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4970000
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-52000
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1728000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
526700000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-33372000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41607000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43567000
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2165000
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6028000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1708000
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11680000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11604000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2305000
CY2021Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
947000
CY2020Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
3409000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20838000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2425000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
332000
CY2021Q2 woof Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss
AmountsReclassifiedOutOfAccumulatedOtherComprehensiveIncomeLoss
0
CY2020Q2 woof Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss
AmountsReclassifiedOutOfAccumulatedOtherComprehensiveIncomeLoss
-2337000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2020Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-553000
CY2021Q2 woof Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
105188000
CY2020Q2 woof Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
108841000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3748000
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3767000
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36008000
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3307000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9140000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6302000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20119000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74074000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2483000
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-10153000
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
66120000
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5853000
CY2021Q2 woof Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
116994000
CY2020Q2 woof Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
64188000
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1859000
CY2020Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3099000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
115002000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32289000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47351000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27895000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47351000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27895000
CY2021Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1700000000
CY2020Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
397000000
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1678111000
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
142313000
CY2021Q2 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
24665000
CY2020Q2 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0
CY2021Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
593000
CY2020Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
935000
CY2021Q2 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
3844000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
253752000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179978000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
348286000
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
49527000
CY2021Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
47000
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. These estimates are based on information that is currently available and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.  </p>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
174034000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111402000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
5944000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
8138000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
179978000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
119540000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414994000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1113521000
CY2021Q2 us-gaap Line Of Credit Facility Covenant Compliance
LineOfCreditFacilityCovenantCompliance
the Company was in compliance with its covenants in the First Lien Term Loan and the ABL Revolving Credit Facility.
CY2021Q2 us-gaap Line Of Credit
LineOfCredit
150000000.0
CY2021Q2 woof Maximum Borrowing Capacity Of Eligible Accounts Receivable In Percentage
MaximumBorrowingCapacityOfEligibleAccountsReceivableInPercentage
0.90
CY2021Q2 woof Borrowing Capacity Of Net Orderly Liquidation Value Of Eligible Inventory In Percentage
BorrowingCapacityOfNetOrderlyLiquidationValueOfEligibleInventoryInPercentage
0.90
CY2021Q2 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
50000000
CY2016Q1 woof Number Of Interest Rate Cap Agreements
NumberOfInterestRateCapAgreements
5
CY2016Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1950000000.0
CY2016Q1 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2021-01-29
CY2021Q2 woof Impairment Of Fixed Asset And Right Of Use Asset
ImpairmentOfFixedAssetAndRightOfUseAsset
1100000
CY2020Q2 woof Impairment Of Fixed Asset And Right Of Use Asset
ImpairmentOfFixedAssetAndRightOfUseAsset
3100000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11604000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2305000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0

Files In Submission

Name View Source Status
0001564590-21-032462-index-headers.html Edgar Link pending
0001564590-21-032462-index.html Edgar Link pending
0001564590-21-032462.txt Edgar Link pending
0001564590-21-032462-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
woof-10q_20210501.htm Edgar Link pending
woof-10q_20210501_htm.xml Edgar Link completed
woof-20210501.xsd Edgar Link pending
woof-20210501_cal.xml Edgar Link unprocessable
woof-20210501_def.xml Edgar Link unprocessable
woof-20210501_lab.xml Edgar Link unprocessable
woof-20210501_pre.xml Edgar Link unprocessable
woof-ex311_9.htm Edgar Link pending
woof-ex312_8.htm Edgar Link pending
woof-ex321_6.htm Edgar Link pending
woof-ex322_7.htm Edgar Link pending